# Varenicline Effects In Schizophrenic Smokers

> **NCT00548470** · PHASE4 · COMPLETED · sponsor: **Nathan Kline Institute for Psychiatric Research** · enrollment: 14 (actual)

## Conditions studied

- Schizophrenia
- Tobacco Use Disorder
- Nicotine Dependance

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT00548470
- **Lead sponsor:** Nathan Kline Institute for Psychiatric Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-09
- **Final completion:** 2010-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548470, "Varenicline Effects In Schizophrenic Smokers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00548470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*